Sign in

CIK 0001723128 · Large accelerated filer

Amneal Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
Phone
(908) 947-3120
Former names
Atlas Holdings, Inc.
  1. 4 Option exercise Director acquired 34,819 shares (option exercise)
  2. 10-Q Report Quarterly Report
  3. 8-K Event Shareholder vote results
  4. 8-K Event Results of operations
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership
  6. DEFA14A Proxy Proxy Materials
  7. DEFA14A Proxy Proxy Materials
  8. DEFA14A Proxy Proxy Materials
  9. DEFA14A Proxy Proxy Materials
  10. DEFA14A Proxy Proxy Materials
  11. DEFA14A Proxy Proxy Materials
  12. DEFA14A Proxy Proxy Materials
  13. 8-K Event Material agreement · Results of operations · Unregistered share sale · Regulation FD disclosure
  14. 4/A Derivatives Options or other derivatives
  15. 4/A Derivatives Options or other derivatives
  16. SCHEDULE 13D/A Stake Beneficial Ownership Report
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. DEFA14A Proxy Proxy Materials
  19. DEF 14A Proxy Proxy Statement
  20. 4 Shares withheld for taxes Co-CEO gave up 361,980 shares (to pay taxes)

Page 3 of 35 · 695 filings